Catalog Number FVL08100 |
Device Problems
Fracture (1260); Misfire (2532)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 05/05/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the fluency plus endovascular stent graft products that are cleared in the us.The pro code and 510 k number for the fluency plus endovascular stent graft products are identified in d2 and g4.H10: as the lot number for the device was provided, a review of the device history record is currently being performed.The return of the sample is pending.However, photos and an image were provided for review.The investigation of the reported event is currently underway.H10: d4 (expiry date: 03/2025).H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3: device pending return.
|
|
Event Description
|
It was reported that during a stent graft placement procedure via the right femoral artery, the device was allegedly unable to be released properly.It was further reported that the blue outer sheath was allegedly fractured due to the failure to deploy the stent.Reportedly, the blue outer sheath was torn by the physician in an attempt to make the stent deploy but still failed.The procedure was completed using another device.There was no reported patient injury.
|
|
Manufacturer Narrative
|
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the fluency plus endovascular stent graft products that are cleared in the us.The pro code and 510 k number for the fluency plus endovascular stent graft products are identified in d2 and g4.H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.Investigation summary: the sample was not available for evaluation.However, photos and an x-ray was provided for evaluation.Based on these images partial stent graft deployment as well as fracture of the outer sheath was confirmed.The system was flushed.However, an 8f introducer sheath was used instead of the recommended 9f.Additionally the system should be straightened prior to deployment and the proximal end of the stent graft should be placed in a straight section of the lumen prior to deployment.In this case the system was straightened prior to deployment.Based on the provided information the investigation is closed with a confirmation for partial deployment and fracture of the outer sheath.The reported use of the device to treat an aneurysm is an off-label use.A definite root cause for the reported event could not be determined.Labeling review: relevant labeling was reviewed, it was found that the instructions for use sufficiently address the potential risks.Regarding preparation of the device the instruction for use state that 'prior to loading the vascular system over a guide wire, both ports must be flushed with sterile saline (.).Flushing these lumens will also facilitate stent graft deployment.' regarding the anatomy of the placement site the instruction for use states: 'prior to stent graft deployment (.), ensure that the proximal stent graft end is positioned in a straight section of the lumen to reduce the risk of increased deployment forces and possible failure to deploy.' regarding stent graft deployment the instruction for use states: 'during release of the stent graft, the entire length of the flexible deployment system should be kept as straight as possible.Regarding accessories the instruction for use states: 'a super stiff guide wire (0.035 in.) is advanced from a femoral artery puncture site.Use an introducer sheath for the implant procedure'; the packaging pictograms indicate an introducer size of 9f and a 0.035" guidewire.It also contains the following precaution: 'the safety and effectiveness of the device for use in the treatment of aneurysms and pseudoaneurysms have not been established'.H10: d4 (expiry date: 03/2025), g3 h11: h6 (method, result, conclusion) h11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Event Description
|
It was reported that during a stent graft placement procedure via the right femoral artery, the device was allegedly unable to be released properly.It was further reported that the blue outer sheath was allegedly fractured due to the failure to deploy the stent.Reportedly, the blue outer sheath was torn by the physician in an attempt to make the stent deploy but still failed.The procedure was completed using another device.There was no reported patient injury.
|
|
Search Alerts/Recalls
|
|